This Avalo Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

• HC Wainwright & Co. analyst Kevin Dede initiated coverage on American Bitcoin Corp (NASDAQ:ABTC) with a Buy rating and announced a price target of $4. American Bitcoin shares closed at $1.51 on Friday. See how other analysts view this stock.
• Ascendiant Capital analyst Edward Woo initiated coverage on Synergy CHC Corp. (NASDAQ:SNYR) with a Buy rating and announced a price target of $5. Synergy CHC shares closed at $1.87 on Friday. See how other analysts view this stock.
• Wells Fargo analyst Benjamin Burnett initiated coverage on Praxis Precision Medicines, Inc. (NASDAQ:PRAX) with an Equal-Weight rating and announced a price target of $282. Praxis Precision Medicine shares closed at $314.00 on Friday. See how other analysts view this stock.
• Guggenheim analyst Yatin Suneja initiated coverage on Avalo Therapeutics, Inc. (NASDAQ:AVTX) with a Buy rating and announced a price target of $50. Avalo Therapeutics shares closed at $15.11 on Friday. See how other analysts view this stock.
• Wells Fargo analyst Benjamin Burnett initiated coverage on Rapport Therapeutics, Inc. (NASDAQ:RAPP) with an Overweight rating and announced a price target of $43. Rapport Therapeutics shares closed at $26.61 on Friday. See how other analysts view this stock.

Considering buying AVTX stock? Here’s what analysts think:

Photo via Shutterstock